Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
NMDA Antagonists for Treatment-Resistant Depression
Nuri B. Farber
Institute of Clinical and Translational Sciences (ICTS)
Department of Psychiatry
Division of Education
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NMDA Antagonists for Treatment-Resistant Depression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Depressive Symptoms
100%
Ketamine
100%
NMDA Antagonist
100%
Treatment-resistant Depression
100%
NMDA Receptor Blockade
100%
Major Depressive Disorder
50%
High Dose
50%
Dosing Schedule
50%
Investigational Agents
50%
Antidepressants
50%
Nitrous Oxide
50%
Best Response
50%
Clinical Development
50%
Dose-ranging
50%
Appropriate Dose
50%
Unwanted Effects
50%
Neuropsychiatric Symptoms
50%
Cognitive Effects
50%
Clonidine
50%
Unwanted Side Effects
50%
Psychotomimetic
50%
Monoaminergic System
50%
Psychotomimetic Effects
50%
Rapid Improvement
50%
Rapastinel
50%
Pharmacology, Toxicology and Pharmaceutical Science
Treatment Resistant Depression
100%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
100%
Side Effect
100%
Ketamine
66%
N Methyl Dextro Aspartic Acid Receptor
66%
Psychotomimetic
66%
Antidepressant
33%
Major Depression
33%
Nitrous Oxide
33%
Clonidine
33%
Rapastinel
33%